Highlights
About
AI Genomics Engine for Disease Treatment
RegulomeX is a pioneering biotechnology startup leveraging advanced artificial intelligence to decode the largely unexplored non-coding regions of the human genome. The company’s proprietary technology, the Regulatory Genome Language Model, harnesses the power of generative AI to uncover regulatory elements that control gene expression, offering groundbreaking insights into the genetic mechanisms underlying complex diseases.
By enabling precise identification of genetic markers and deciphering complex genetic interactions, RegulomeX is setting new standards in personalized medicine and drug discovery. Its mission is to transform healthcare by developing targeted therapies that are finely tuned to individual genetic profiles, significantly improving patient outcomes and extending lives.
Identity
| Name | RegulomeX |
|---|---|
| Slug | regulomex |
| Type / kind | startup |
| Source _id | PPsUPkbWUMZRwEwfQhnhhYxWA1MozBz1evMDBhPCqAfehYpCNR0GSl |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Sep 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/102558353/ | |
| YouTube | https://www.youtube.com/@RegolumeX-xf5fb |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}